Close
Help




JOURNAL

Clinical Medicine Insights: Oncology

499,925 Journal Article Views | Journal Analytics

Clinical Management of Localized Colon Cancer with Capecitabine

Submit a Paper



Publication Date: 05 Nov 2012

Type: Review

Journal: Clinical Medicine Insights: Oncology

Citation: Clinical Medicine Insights: Oncology 2012:6 363-373

doi: 10.4137/CMO.S8194

Abstract

Large randomized trials demonstrated a benefit of adjuvant chemotherapy after resection of the primary colon cancer. It improves overall survival and reduces the risk of death, by 5% in UICC (Union Internationale Contre le Cancer) stage II and approximately 15%–20% in stage III. Fluoropyrimidines have been the standard drugs for the treatment of colon cancer since large randomized controlled trials demonstrated their efficacy and safety in treating patients suffering from this disease. Capecitabine is an orally administered fluoropyrimidine, which is preferably activated in tumor tissue to the active moiety 5-fluorouracil (5FU) and is cytotoxic through inhibition of DNA synthesis. It has proven equivalent efficacy and tolerability despite a changed toxicity profile compared to 5FU with less myelosuppression but more hand-and-foot syndrome. Capecitabine is well tolerated in elderly patients. The oral route of administration avoids frequent clinical visits as well as insertion of central venous catheters. The impact of the particular drug features on daily clinical practice is discussed in this review.


Downloads

PDF  (548.03 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML






What Your Colleagues Say About Clinical Medicine Insights: Oncology
I must really send you all my compliments for your prompt processing and very uncomplicated way of dealing with manuscripts.  Thank you very much for keeping up with all these details!  I will surely recommend your journal and publishing group to other colleagues.
Dr Tsambika A. Psaras (Universitätsklinik für Neurochirurgie, Tübingen, Germany)
More Testimonials

Quick Links


New article and journal news notification services